Latest Malin News & Updates

See the latest news and media coverage for Malin. We track all announcements, press releases, and industry mentions in real time, all in one place.

Malin

Publicly listed life sciences investment company

malinplc.com

Headquarters: Dublin 2, Ireland
Founded year: 2015
Company type: Public company
Number of employees: 10–50
Industry: Investment Holding Companies

Last updated Today

Latest news about Malin

In short: Malin reported 2026 interim results with a share value of €9.36 following significant capital returns and the sale of Poseida to Roche.

Company announcements

August 26 Malin

Malin reports its 2026 interim financial results and valuations

The company discloses an estimated intrinsic equity value of €9.36 per share at mid-year and details changes in its investment portfolio including Poseida and Kymab.

July 24 Malin

Malin investee Sanofi discontinues amlitelimab in atopic dermatitis

The decision follows a strategic assessment; safety and efficacy data did not show meaningful improvement over standard of care. No impact on Sanofi's 2026 guidance.

January 23 Malin

Sanofi announces positive phase 3 results for amlitelimab

Amlitelimab met key endpoints in SHORE and COAST 2 studies for atopic dermatitis treatment. Sanofi plans global regulatory submissions in H2 2026.

18 November 2025 Malin

Mycovia announces publication of 2-year VIVJOA efficacy results

The VIOLET Phase 3 extension study showed 98% of women remained infection-free versus 82% on placebo for nearly two years. VIVJOA is FDA-approved for RVVC in non-reproductive potential women.

Media coverage

July 27 The Irish Times

Malin misses out on $25.9m earnout as centrepiece drug key 2021 deal is scrapped

Malin Corporation will receive less than 80 per cent of the $33 million (€29 million) in earnout payments tied to the 2021 sale of its...

March 27 The Globe and Mail

Malin shareholders back all resolutions at 2026 AGM

Malin Corporation plc, the Ireland-based life sciences investment company listed on Euronext Growth Dublin, targets innovative healthcare businesses worldwide, backing firms built on strong scientific...

March 10 Business Post

Iseq ends trading up over 2.8%, with Malin and Bank of Ireland leading the gains

The Iseq All Share ended Tuesday trading up nearly 3 per cent, with Bank of Ireland... February was a month of two halves for investors...

February 26 The Irish Times

Malin CEO to leave and chair take on executive role as portfolio shrinks

Malin Corporation said its chief executive Fiona Dunlevy is leaving the Dublin-listed life sciences investment company as the value of its investments shrank by 80...

Never miss news about Malin

Track Malin and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Malin competitors & trending companies

Browse news for competitors to Malin and other trending companies.